Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Synthetic Secretin (ChiRhoStim) vs Teduglutide (Gattex)
An educational, source-based comparison of Synthetic Secretin (ChiRhoStim) and Teduglutide (Gattex) — how each peptide works, what it's researched for, and what to know before going deeper.
27-amino-acid peptide used to stimulate pancreatic secretions for diagnosis.
Synthetic human secretin that stimulates pancreatic bicarbonate, fluid secretion, and gastrin release — used diagnostically for pancreatic function, gastrinoma evaluation, and ERCP facilitation.
- Pancreatic function testing
- Gastrinoma (Zollinger-Ellison) diagnosis
- ERCP facilitation
- • FDA-approved.
- • Single diagnostic dose; minimal adverse effects.
GLP-2 analog for short bowel syndrome dependent on parenteral support.
Recombinant analog of glucagon-like peptide-2 with alanine→glycine substitution at position 2, resisting DPP-IV degradation; promotes intestinal mucosal growth, villus height, and absorptive capacity.
- Short bowel syndrome with intestinal failure
- Reduction of parenteral nutrition dependence
- • FDA-approved.
- • Colorectal polyp surveillance required.
- • Risk of intestinal obstruction and biliary/pancreatic disease.
Synthetic Secretin (ChiRhoStim) vs Teduglutide (Gattex) — Key differences
- Class: Synthetic Secretin (ChiRhoStim) is classified as Diagnostic · Gastroenterology, while Teduglutide (Gattex) is GLP-2 Analog · Gastrointestinal.
- Primary research focus: Synthetic Secretin (ChiRhoStim) — pancreatic function testing; Teduglutide (Gattex) — short bowel syndrome with intestinal failure.
- Tag: FDA-Approved · Diagnostic vs FDA-Approved · GI.